RxDoctor Payments Data

Zachary Ford

Family · Collinsville, ILNPI 1952057903

Payments from drug & device makers

$646in general payments, 2019–2025

Across 39 payments — averaging $16.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$238
  • Lilly USA, LLC$134
  • Novo Nordisk$44
  • Lundbeck LLC$42
  • Amgen$37
  • Aimmune Therapeutics, Inc.$33
  • plus $118 from 7 others

What the payments were for

  • Food & beverage$646100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$646 in reported general payments places this provider in the 65th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Medicare billing

Part B allowed, 2024
$23,018
Medicare patients
125
Services billed
330

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide31$38,705
EliquisApixaban34$34,271
OzempicSemaglutide25$26,605
MounjaroTirzepatide19$23,055
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$13,895
UbrelvyUbrogepant13$12,901
LinzessLinaclotide16$11,991
JanumetSitagliptin Phos/Metformin Hcl11$9,749
Combivent RespimatIpratropium/Albuterol Sulfate12$8,760
XareltoRivaroxaban11$6,556
NamzaricMemantine Hcl/Donepezil Hcl11$5,582
SymbicortBudesonide/Formoterol Fumarate18$4,297
DuleraMometasone/Formoterol11$3,928
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$2,564
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen95$2,475

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$134$61,76050 claims
AbbVieUbrelvy, Linzess, Namzaric$238$30,47440 claims
Novo NordiskOzempic$44$26,60525 claims
AstraZenecaSymbicort$19$4,29718 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,941 family providers in Illinois.

Other family in Collinsville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →